Introduction
Temporal control of the transcription of geneswhose products contribute to cell cycle progression is critical for accurate transmission of genetic information and controlled cell replication. Central to the temporal control mechanism is a relationship between the behavior of certain transcription factors that contribute to cell cycle-dependent gene control,e.g., theE2Ffamily (Nevins, 1992; LaThangue, 1994 ) and the activities of proteins that orchestrate individual cell cycle events, the cyclin-cdk complexes (Hunter and Pines, 1994) .
The molecular mechanisms by which cyclin-cdk complexes modulate the activity of E2F is best understood in the case of E2F-1, a transcription factor involved in the timely activation of genes whose products contribute to Gl exit and S phase traverse. According to a current model, during mid-to late-Gl, E2F-1 (Helin et al., 1992; Kaelin et al., 1992; Shan et al., 1992) bound to its heterodimeric DP partner (Girling et al., 1993) complexes with the un(der)phosphorylated species of pRB. Cyclin D-cdkC or cyclin D-cdk6-dependent phosphorylation of pRB in midto late-G1 (for reviews see Sherr, 1993; Weinberg, 1995) results in the dissociation of E2F-1 (bound to DP). E2F-1 is, in turn, freed of pocket protein regulation, and certain E2F-l-responsive promoters, including at least some that govern the synthesis of products that stimulate cell cycle progression, are activated. As cells complete Gl and move into S, E2F-1 forms stable complexes with cyclin A-kinase. The bound enzyme, in turn, phosphorylates EPF-l-bound DP-1. This reaction leads to suppression of E2F-1 DNA-binding activity (Krek et al., 1994) . A possible consequence of this effect is diminished activation of the above-noted, E2F-stimulated promoters. Indeed, certain E2F-dependent promoters (Means et al., 1992; Lam and Watson, 1993) are both activated in late-G1 and subsequently inactivated in S in an E2F site-dependent manner. These conclusions are supported by the findings of Dynlacht et al. (1994) who developed an in vitro transcription assay that recapitulates E2F-specific transactivation through a cognate E2F DNAbinding site. Addition of purified cyclin A-cdk2 to this E2F-responsive assay led to phosphorylation of E2F-I-DP-1 heterodimers and loss of E2F-l-dependent DNA binding and transactivation function. Cyclin E-cdk2, by contrast, was inactive in this system.
That cyclin A-kinase alone was active here is compatible with the fact that the E2F-1 cyclin-binding sequence failed to bind cyclin E-kinase or any other cyclin (Krek et al., 1994) . Of note, cyclin A-kinase function is essential for S phase progression (Girard et al., 1991; Pagan0 et al., 1992; Zindy et al., 1992) .
Thus, it appears that E2F-1 function is tightly controlled in Gl and S. The time-controlled activation of E2F-1 in mid-to late-G1 as well as its time-controlled inactivation in S is triggered by distinct classes of cyclin-cdk complexes and, thus, provides one paradigm for how waves of gene expression are generated in mammalian cells at specific cell cycle intervals.
No information exists regarding the biological consequencesof adysfunctional cyclin A-kinase-E2F-1 interaction during S phase. In this report, we describe results that provide evidence that timely regulation of E2F-1 DNA binding function by a cyclin A-kinase is essential for orderly S phase progression, cell survival, and suppression of fibroblast transformation.
Thus, one aspect of the largely unknown S phase regulatory function(s) of cyclin A-kinase may be mediated through its ability to modulate the behavior of E2F-1.
Results

E2F-1 Mutants Defective in Cyclin A-Kinase
Binding Cause Apoptosis of Fibroblasts in High Serum To probe the biological effect(s) of cyclin A-kinase-E2F-1 complex formation, recombinant retroviruses ( Figure 1A ) were used to introduce hemagglutinin (HA)-tagged versions of E2F-l(wt) and mutant derivatives of it that are defective in cyclin A-kinase binding, i.e., E2F-l(A24) and E2F-l(A7) (Krek et al., 1994) into NIH 3T3 fibroblasts. The goal of introducing these mutants was to bypass the kinase function of cyclin A-kinase-E2F-1 -DP complexes. This viral production system (see Experimental Procedures) led to high titer retrovirus stocks enabling quantita- tive infection of a large cell population. In addition, although each recombinant retrovirus encoded a puromycin resistance allele, no drug selection was applied in this first set of E2F-1 infection experiments.
To detect the production of the relevant HA-tagged E2F-1 products, extracts were prepared from each of the infected cultures 24 hr postinfection (hpi), and equivalent amounts of cell protein from each were subjected to Western blotting with an anti-HA antibody. As shown in Figure  1 B, similar levels of each of the expected E2F-1 species were present (lanes 2-4). None were detected in vectorinfected cell extracts (Figure 1 B, lane 1) . Thus, any differences in the behavior of wild-type or mutant E2F-1 -infected cell populations cannot be ascribed to differences in the quantity of E2F-1 proteins present.
Microscopic examination of cells infected with the aforementioned retroviruses revealed no significant morphological changes at 24 hpi (Figure 2A, left were observed in either vector-infected or wild-type E2F-linfected cells (Figures 2Ab and 2Ad , respectively). These data suggest that time-dependent cyclin A-kinase-EPF-1 binding is critical for the maintenance of normal cell morphology and cell survival. In addition, that practically all cells of an E2F-l(A24)-or E2F-l(A7)-infected culture were morphologically altered suggests that the efficiency of infection was high.
Next, we asked whether E2F-l(A24)-or E2F-l(A7)-induced death of NIH 3T3 was due to apoptosis. Key features of this process are chromatin condensation and internucleosomal DNA fragmentation. As visualized by staining with 2,4-diamidino-2-phenylindole (DAPI), significant numbers of E2F-l(A24)-or E2F-l(A7)-infected cultures contained condensed chromatin (Figures 2Bc and  2Bd) . In contrast, vector-infected or wild-type E2F-linfected populations contained few cells with altered chromatin structure (Figures2Ba and 2Bb) . Moreover, the DNA of E2F-1 (A24)-or E2F-1 (A7)-producing cells produced a characteristic "ladder" in agarose gels ( Figure 2C , lanes 3 and 4). Neither vector-infected nor wild-type E2F-linfected cells contained degraded DNA( Figure 2C , lanes 1 and 2). These observations indicate that uncoupling E2F-1 from its natural S phase regulator, cyclin A-kinase, results in the activation of an intrinsic cell suicide (apoptosis) program. Since E2F-l(A24)-or E2F-l(A7)-mediated apoptosis occurred in the presence of high serum, one could argue that death, in this case, was not due to growth or survival factor deficiency (or both), but rather to perturbations of cell cycle progression.
S Phase Delay/Arrest
Precedes E2F-1 (A24)-or E2F-l(A7)-Induced Apoptosis To investigate whether E2F-l(A24)-or E2F-l(A7)-induced apoptosis was a consequence of a perturbation in the cell cycle, we analyzed the DNA content of each of the infected cell populations by fluorescence-activated cell sorting (FACS) at various times after infection. At 24 hpi, most cells of vector-infected cultures were in Gl and S (44% and 38%, respectively); 18% of the culture had a G2/M DNA content ( Figure 3A , left, bars marked vet). This cell cycle profile resembled closely that of exponentially growing uninfected NIH 3T3 cells (data not shown). Wild-type E2F-l-infected cells displayed a similar cell cycle profile ( Figure 3A , left, bars marked wt). By contrast, most cells
7" , 24 hour\ p / 18 ,,""I\ p I I '01-from E2F-1 (A24)-or E2F-1 (A7)-infected cultures were in S phase (54% and 52%, respectively) ( Figure 3A , left, bars marked A24 and A7).
At 48 hpi, the profiles of the vector-infected or wild-type E2F-l-infected cultures were similar to those at 24 hpi ( Figure 3A , right, bars marked vet and wt). Most E2F-l(A24)-or E2F-l(A7)-infected cells remained in S ( Figure  3A , right, bars marked A24 and A7). However, in contrast with the 24 hr timepoint, these cultures contained fewer G2/M cells and an increased number of Gl cells ( Figure  3A , right, bars marked A24 and A7). These results suggest that normal progression through S phase can be linked to the existence of stable cyclin A-kinase-E2F-1 complexes. Consistent with the above (see Figure 2) , we observed at 48 hpi a new subpopulation of cells in E2F-l(A24)-or E2F-1 (A7)-infected cultures that was characterized by less than a 2n DNA content. Owing to chromatin condensation and DNA cleavage, apoptotic cells show less propidium iodide fluorescence than viable cells and, thus, appear as a subdiploid population (Nicoletti et al., 1991) . Approximately 20% of cells from E2F-l(A24)-or E2F-l(A7)-infected cultures were apoptotic by this criterion ( Figure  38 , bars marked A24 and A7). Analogous cells were absent from the vector-infected or wild-type E2F-l-infected cultures ( Figure 3B , bars marked vet and wt).
Induction of S Phase Delay/Arrest
by a DP-1 Mutant That Cannot Be Phosphorylated by EPF-l-Bound Cyclin A-Kinase Earlier results pointed to DP-1 as a key physiological substrateofcyclin A-kinase boundtoE2F-1 (Kreketal., 1994). Moreover, a strict correlation between E2F-1 -bound cyclin A-kinase phosphorylation of DP-1 on serine and loss of E2F-1 DNA-binding activity was demonstrated. Given the linkage between a defect in cyclin A-kinase binding to E2F-1 and S phase arrest/delay, we analyzed the behavior of cells producing a DP-1 mutant that cannot be phosphorylated by cyclin A-kinase. The coding region of mouse DP-1 (Girling et al., 1993) contains a cluster of cdk phosphorylation sites (SP and TP motifs) near the N-terminus. Therefore, a mutant of DP-1 lacking these potential phosphoacceptor sites was constructed and equipped with an N-terminal T7 tag. This species, T7-DP-1 (AP), bears serine to alanine substitutions at positions 23,80, and 98 and threonine to alanine substitutions at positions 66 and 83. No other SP motifs exist in the DP-1 sequence. The sole remaining TP site (at position 388) was not modified, since phosphorylation of DP-1 in vivo by the E2F-l-bound cyclin A-kinase likely occurs predominantly, if not exclusively, on serine.
The resulting mutant protein appeared to be as stable as wild-type DP-1, as measured in [35S]methionine-labeling experiments (data not shown), and like wild-type DP-1, it formed stable heterodimers with wild-type E2F-1 as shown in gel shift assays ( Figure 4A , compare lanes 4-6 with lanes 7-9). The heterodimer also bound cyclin A-kinase in vivo ( Figure 48) ; however, T7-DP-l(AP) (lane 2), unlike T7-DP-l(wt) (lane l), was barely labeled when an anti-HA immunoprecipitate from cells cotransfected with HA-E2F-l(A5) (this pocket protein binding-defective mutant of E2F-1 was chosen for this experiment to avoid potential contamination of the anti-HA immunoprecipitate with any kinase that coprecipitates in a pocket-dependent fashion) and the mutant was exposed to an in vitro kinase reaction (compare lanes 2 and 1). The small amount of residual mutant DP-1 labeling was expected based on prior results (Krek et al., 1994) and likely reflects in vitro only labeling of non-SP sites (e.g., the intact C-terminal TP site) by E2F-l-bound cyclin A-kinase. By contrast, E2F-1 (A5) was labeled in both cases ( Figure 48 , lanes 1 and 2), in keeping with the prior observation that both E2F-1 and DP-1 are overtly phosphorylated in vitro when E2F-1 can bind cyclin A-kinase (Krek et al., 1994) . Therefore, by multiple criteria, the mutant protein behaved similarly to wild-type protein, with the exception of a marked decrease in in vitro phosphorylation, reflecting a defect in cyclin A-kinase labeling.
Recombinant retroviruses encoding T7-tagged versions of DP-l(AP) and wild-type DP-1 were used to infect NIH 3T3 cells. Stably infected cultures were selected as pools of puromycin-resistant cells (uncloned mass cultures). These pools contained equivalent amounts of T-/-tagged DP-1 protein, as shown by Western blotting ( Figure 4C , compare lanes 2 and 3).
In multiple, independent experiments, these two pools were superinfected with equivalent amounts of wild-type E2F-l-encoding virus. In each case, shortly after infection, there was accumulation of S phase cells only in the mutant DP-l-containing culture ( Figure 4D ). The accumulation effect was similar to that observed in the experiment shown in Figure 3A , in which linkage between binding of cyclin A-kinase to E2F-1 and normal passage through S phase was demonstrated. Therefore, S phase accumulation, the biological phenomenon most closely associated with nonbinding of cyclin A-kinase to E2F-1, can also be linked to inability of E2F-l-bound kinase to phosphorylate DP-1.
Characterization of E2F-l(A24) Double Mutants Specifically
Defective in DNA Binding and Transactivation To test whether E2F-1 DNA binding or transactivation function (or both) contributes to the ability of the cyclin A-kinase binding-defective mutant E2F-l(A24) to induce S phase delay/arrest and subsequent apoptosis, retroviral expression plasmids encoding HA-tagged versions of the with expression plasmids encoding HA-E2F-l(wt) (10 ug) and T7-DP-l(wt) (10 ug) (lanes 4-6) or HA-EPF-l(wt) (10 ug) and T7-DP-l(AP) (IO ug) (lanes 7-9) were subjected to immunoprecipitation with the anti-HA MAb 12CA5. lmmunoprecipitates were washed and treated with HA peptide (at a concentration of 2 mg/ml) to disrupt the antibody-antigen interaction, and supernatants were analyzed by EMSA for E2F DNA-binding activity in the absence (lanes 1, 4, and 7) or presence of either anti-T7 MAb (lanes 2, 5, and 6) or control antibody PAb 419 (lanes 3, 6, and 9). Note the specific supershift effect in lanes 5 and 6, indicating that T7-tagged DP-l(wt) and T7-tagged DP-I(AP) had coimmunoprecipitated with HA-E2F-l(wt). (B) Whole-cell lysates of U2-OS cells, either not transfected (lane 3) or cotransfected with expression plasmids encoding HA-E2F-l(A5) (10 ug) and T7-DP-l(wt) (10 ug) (lane 1) or HA-E2F-l(A5) (10 ug) and TFDP-l(AP) (10 pg) (lane 2) were subjected to immunoprecipitation with the anti-HA MAb 12CA5. lmmunoprecipitates were washed and subjected to an in vitro kinase reaction in the presence of [y-"PJATP. The migration positions of in vitro phosphorylated HA-EPF-l(A5) and coprecipitated T7-DP-l(wt) and T7-DP-l(AP) are denoted. Note that compared with T7-DP-l(wt) (lane l), T7-DP-l(AP) (lane 2) was poorly labeled under these conditions. (C) NIH 3T3 cells were infected with vector, T7-DP-I(wt), or T7-DPl(AP) virus. After selection in puromycin, mass cultures (cell pools) of stably infected, puromycin-resistant cells were established. Lysates were prepared from each cell pool grown in parallel. These lysates were equalized for protein content and processed for Western blotting with anti-T7 MAb. Lane 1, vector-infected NIH 3T3 cells; lane 2, T7-DPl(wt)-producing pool; lane 3, T7-DP-l(AP)-producing cell pool. Note that equivalent amounts of T7-tagged DP-1 proteins were present in the relevant cell pools. These pools were used in the experiments described in (D). (lanes 5 and 6) HA-EPF-I(-DB) (lanes 7 and 8) HA-EPFi(A24/-DB) (lanes 9 and IO), HA-EZF-I(-TA) (lanes 11 and 12) or HA-E2F-l(A24/-TA) virus (lanes 13 and 14) and analyzed by EMSA for E2F DNA-binding activity in the absence (lanes 1, 3, 5, 7, 9, 11, and 13) or presence (lanes 2, 4, 6. 8, 10, 12, and 14) of the anti-HA MAb 12CA5.
defective mutant (E2F-I(-TA);
see Flemington et al., 1993) and the double mutant derivative of it, also defective in cyclin A-kinase binding, E2F-l(A24/-TA) ( Figure 5A ). Recombinant retroviruses encoding these HA-tagged E2F-1 proteins were generated and used to infect cultures of NIH 3T3 cells. All E2F-1 species under investigation were synthesized 24 hr after infection, as shown by Western blotting (Figure 58, lanes 2-7) . Although there are variations in the abundances of the various E2F-1 species that were produced, we note that comparable quantities of each pair of E2F-1 proteins (the single mutant and the cognate A24 double mutant) were present (e.g., compare lanes 6 and 7). Thus, one can compare the behavior of a given E2F-1 species with its cyclin A-kinase bindingdefective counterpart in a series of biological assays.
As shown in Figure 5C , when anti-HA immunoprecipitates of NIH 3T3 cultures previously infected with the various E2F-l-encoding retroviruses were tested for associated kinase activity, only the E2F-1 alleles with an intact cyclin A-binding domain, i.e., E2F-l(wt) (lane 2) E2F-1 (-DB) (lane 4) and E2F-1 (-TA) (lane 6), displayed histone Hl kinase activity. Thus, cyclin A-kinase binding to these various E2F-1 species was present where expected.
The various E2F-1 species were also tested for DNAbinding activity. Whole-cell extracts were prepared in parallel from NIH 3T3 cultures infected either with vector virus or with viruses encoding the various E2F-1 alleles and were tested in E2F gel shift assays ( Figure 5D ). To distinguish between endogenous and exogenous E2F-lcontaining gel shift complexes, each sample was treated in parallel with anti-HA antibody, in search of a specific supershift effect. Extracts from vector-infected cells contained two major bands ( Figure 5D , lane 1). and as expected, addition of anti-HA antibody failed to supershift either (lane 2). In E2F-l(wt)-and E2F-l(A24)-infected cells, an additional band was apparent ( Figure 5D , lanes 3 and 5) that supershifted upon addition of anti-HA antibody (lanes 4 and 6) indicating the presence of HA-EPF-l(wt) and HA-E2F-l(A24), respectively. As expected, in cells infected with those mutants that can no longer bind to DNA, E2F-l (-DB) and E2F-l(A24/-DB), no additional complexes were detected beyond those present in the vector-infected population ( Figure 5D , lanes 7 and 9) and none were supershifted by anti-HA antibody (lanes 8 and 10). By contrast, extracts of cells infected with E2F-1 mutants unable to transactivate, E2F-1 (-TA) and E2F-1 (A24/ -TA), each contained a major band ( Figure 5D , lanes 11 and 13), which was supershifted by the antibody (lanes 12 and 14). Thus, as expected, deletion of the transactivation domain did not suppress E2F-1 DNA-binding activity. These results suggest that the relevant E2F-1 species are stably produced in vivo and behave as expected in various functional assays.
E2F-l(A24)-Induced
S Phase Delay/Arrest and Apoptosis Require Different Functional Domains Next, we analyzed the cell cycle behavior of NIH 3T3 cells infected in parallel with each of the mutant viruses described above. We also sought the appearance of subdiploid cells as an indication of apoptosis. The cell cycle profiles ( Figure 6A ) and the fraction of cells that were subdiploid ( Figure 6B ) in the infected cultures were recorded at the indicated times. Two major conclusions can be drawn from the results. First, S phase delay/arrest and apoptosis require, at aminimum, a functional DNA-binding domain, since cells infected by E2F-1 (A24/-DB), a mutant that is defective in both cyclin A-kinase binding and DNA binding, did not alter the cell cycle profile of NIH 3T3 cells ( Figure 6A , bars marked A24/-DB), nor did it induce apoptosis ( Figure 6B , bar marked A24/-DB). Second, the transactivation domain is dispensable for efficient S phase delay/arrest, but is required for apoptosis. At 24 hpi, a culture producing E2F-l(A24/-TA), a mutant defective in cyclin A binding and in transactivation, revealed a dramatic increase in S phase cells ( Figure 6A , top, bars marked A24/-TA). E2F-1 (A24)-infected cells, analyzed in parallel, revealed a similar profile ( Figure 6A , top, bars marked A24). At 48 hpi, the majority of the E2F-i(A24/ -TA)-infected cells were still in S phase ( Figure 6A , bottom, bars marked A24/-TA), but did not die (Figure 66 , bar marked A24/-TA). In keeping with prior results (see Figure  38 ), a significant fraction of E2F-l(A24)-producing cells were subdiploid at that time and were, therefore, apoptotic ( Figure 6B , bar marked A24).
Importantly, no cell cycle effects were observed in cultures producing a species of E2F-1, E2F-I (-TA) , that is defective in transactivation and pocket protein binding, but is otherwise intact ( Figure 6A , bars marked -TA). This species bound cyclin A-kinase (see Figure 5C ). Thus, one might argue that S phase delay/arrest is mediated by the unscheduled binding of E2F-1 to specific DNA sequences that results, at least in part, from failure of cyclin A-kinase to bind to E2F-1 and to phosphorylate DP-1. The latter translates into an inability to eliminate the DNA binding function of the heterodimer in S (Krek et al., 1994) . In keeping with this explanation, cells synthesizing comparable quantities of a mutant unable to bind both cyclin A and DNA (A24/-DB) failed to delay/arrest in S phase and to die (Figure 6 ). Therefore, the apoptotic response requires both unscheduled, specific E2F-1 DNA-binding activity and the presence of an E2F-1 transactivation domain. The production of the relevant E2F-1 proteins in these various mutant and wild-type virus-infected cell pools was assessed by Western blotting with an anti-HA antibody. As shown in Figure 7A , the HA-tagged E2F-1 mutant proteins, i.e., E2F-I(-DB), E2F-l(A24/-DB), E2F-I(-TA), and E2F-l(A24/-TA), were readily detected as distinctive bands of roughly equivalent intensity at the expected positions (lanes 4-7, respectively). Thus, E2F-l(A24/-TA)-induced S phase arrest was transient, and cells synthesizing the double mutant protein eventually resumed replication.
E2F-l(wt)-infected pools contained significantly less E2F-1 protein than pools infected with the respective DNAbinding or transactivation-defective mutants. No HAreactive bands were detected in pools established from vector-infected cells ( Figure 7A , lane 1). Finally, in agreement with the fact that production of E2F-1 (A24) provoked wide spread apoptosis, E2F-l(A24) bands were absent from the established pool(s) of survivors that were tested ( Figure 7A, lane 3) .
Since some of these cultures had broken through at least one level of S phase control, they were tested for other evidence of growth deregulation. Surprisingly, both the E2F-l(A24/-TA) pool and the culture synthesizing E2F-I(-TA), evaluated as a control, grew in agar ( Figures  7Bf and 7Be , respectively) and formed tumors in nude mice ( Figure 7C) . Notably, the former grew more efficiently in both assays (compare Figures 7Bf and 7Be as well as the left and right solid bars in Figure 7C ), although equivalent quantities of these two proteins were present in the cells that were analyzed ( Figure 7A) .
NIH 3T3 cells infected with wild-type E2F-1 virus also grew in agar (Figure 7Bb ), as reported earlier (Xu et al., 1995) . As expected, neither naive NIH 3T3 (Figure 7Ba ), nor pools containing E2F-1 species lacking DNA binding function (Figures 7Bc and 7Bd ) scored positively in these tests. These data suggest that an E2F-1 species that is intact, except for its ability to both transactivate and bind to RB, is an oncogene. In addition, failure of cyclin A-kinase to bind to E2F-1 appears to heighten, significantly, the oncogenic action of this truncated protein.
Discussion
The results reported here indicate that cyclin A-kinase regulation of E2F-1, a transcription factor equipped with a dedicated cyclin A-kinase-binding domain, promotes uninterrupted S phase passage and cell survival. It appears that phosphorylation of the E2F-1 heterodimeric partner, DP-1, on a specific cyclin-cdk phosphoacceptor site(s) by E2F-l-bound cyclin A-kinase is linked to the suppression of E2F-l-dependent S phase arrest/delay. Thus, we propose that E2F-1, the DNA binding function of which is normally down-regulated in S phase by bound cyclin A-kinase (Krek et al., 1994) participates in the activation of a specific cell cycle checkpoint when regulation by cyclin A-kinase fails. Activation of this checkpoint was only observed when the cyclin A-less transcription factor could still perform its sequence-specific DNA binding function. Thus, one might argue that, for normal cell cycling, the presence of E2F-1 on cognate DNA sequences must be confined to a specific time interval in the cell cycle.
Given these observations, it is tempting to speculate that there is a cellular monitoring system that is, in part, capable of sensing DNA-bound E2F-1 (or certain of its mutant derivatives) and that when it does so after a certain point in S, a checkpoint is activated.
Since E2F-1 (A24/-TA) and E2F-l(A24) both induced S phase arrest/delay, but only the latter induced arrest/delay and death, it would appear that these two biological outcomes are, in part, dissociable. The delay/arrest phenotype is apparently a product of E2F-1 functions short of full, sequence-specific transcription activation. Included among them is specific DNA binding. By contrast, for cell killing, full E2F-1 function appeared to be necessary, as if continuous E2F-1 stimulation of certain promoters after S phase arrest/delay contributed significantly to the ensuing apoptosis.
In normal cells, E2F-1 is bound to DNA during part of Gl and early S, and this timing contributes to its normal function. For example, E2F-1 species that are defective in DNAbindingcannotdriveaGOcellintoS(Johnsonetal., 1993; Shan and Lee, 1994) . In light of the results reported here, one might further suggest that unscheduled E2F-1 DNA-binding activity during S phase interferes with the ongoing DNA replication process. For example, the binding of E2F-1 to certain promoters during S phase might, in theory, prevent the normal passage of selected replication forks. One outcome of such a circumstance might be stalling of the relevant replication complexes and delayed progression of cells through S phase. In this regard, an origin of replication has been mapped downstream of the DHFR gene (Burhans et al., 1990) . Moreover, a functional E2F-binding site exists in the promoter of that gene (Blake and Azizkhan, 1989) . E2F binding to that site contributes to the late-G1 activation of this promoter (Means et al., 1992) .
Conceivably, prolonged binding of E2F to that site perturbs the procession of replication forks emerging from the nearby origin. Clearly, other possibilities exist. However, existing evidence suggests a relationship between replication timing and the transcription of certain genes (for recent review see Coverley and Laskey, 1994) . Thus, coupling the timing of transcription of at least some genes to the control of replication may be critical for normal cell cycle progression.
The failure of cyclin A-kinase to bind to E2F-1 was associated with the accumulation of S phase cells. This, most likely, reflects the development of S phase arrest/delay as opposed to selective death of Gl cells. First, after introducing the relevant E2F-1 mutants, there was overt accumulation of S phase cells (at 24 hr) before the appearance of apoptotic cells, as measured by any of the assays employed. Second, by 48 hr after infection with E2F-l(A24) virus, most of the cells were in the process of dying, and the majority of the cell population at the time were S phase cells. Third, at 48 hr after infection, there was a relative enrichment of Gl cells in the E2F-l(A24)-infected culture (see Figure 3A) .
It also seems unlikely that the observed accumulation of S phase cells resulted from E2F-1 stimulation of Gl exit. In support of this, E2F-l(A24) and E2F-l(A24/-TA) induced roughly equivalent degrees of S phase cell accumulation, yet without its transactivation domain, E2F-1 was unable to drive Gl cells into S phase (Johnson et al., 1993; Shan and Lee, 1994) .
The E2F-l-dependent death observed during the experiments described here does not appear to be a result of the mechanism underlying previously documented, E2F-ldependent apoptosis in growth factor-deprived cells (Shan and Lee 1994; Qin et al., 1994; Wu and Levine, 1994; Kowalik et al., 1995) . In all of the experiments reported here, cells were cultivated in high serum-containing medium, which was shown to suppress E2F-l-dependent death in growth factor-deprived cells. That NIH 3T3 cells producing DP-l(AP) were not growth arrested per se requires comment. In prior experiments, it was shown that the endogenous levels of DP-1 in various cells are high and that there was much more DP-1 than E2F-1 in those cells that have been tested (Girling et al., 1993) . Moreover, it was shown that overproduction of E2F-1 recruits endogenous DP-1 into functional heterodimeric complexes. In contrast, a minimal or no effect was seen when DP-1 was overproduced (Krek et al., 1993; Helin et al., 1993; Bandara et al., 1993) . Hence, one can speculate that, even in cells producing ectopic DP-l(AP), a phenotype resulting from the phosphosite mutations may not come to light until the E2F level is increased, e.g., by E2F-1 recombinant retroviral infection.
As expected, wild-type E2F-l-infected cells displayed transformed characteristics. Indeed, E2F-1 has been shown to transform fibroblast cell lines, to render them tumorigenic, and to be down-modulated as an oncoprotein by pRB binding (Singh et al., 1994; Johnson et al., 1994; Xu et al., 1995) . Yet, two observations were surprising. First, cells infected by a retrovirus encoding an E2F mutant lacking a transactivating domain, E2F-l(-TA), grew in agar and formed tumors in nude mice. On the other hand, an otherwise intact E2F species unable to bind to DNA was inactive in this regard. Thus, one could argue that E2F-I (-TA) transforms, in part, through its DNA binding function. One explanation of how this might occur is based upon recent evidence that RB-E2F-1 complexes bind to certain E2F site-containing promoters and repress their function, thereby resulting in Gl arrest (Bremner et al., 1995; Weintraub et al., 1995; Sellers et al., 1995) . That being the case, it is possible that E2F-I(-TA), which heterodimerizes with DP, binds to E2F sites ( Figure 5D ) and, lacking pRB binding function, competes with RB-EPF complexes for binding to DNA. This might, in turn, relieve repression of certain promoters and overcome the proliferation block.
The second unexpected observation was that cells synthesizing E2F-I(-TA) displayed a less potent transformed phenotype than cells producing comparable amounts of E2F-1 (A24/-TA). This suggests that cyclin A-kinase binding to E2F-1 suppresses its transforming function. Whether this depends upon DP-1 serine phosphorylation, like progression through S phase, is unknown. However, this effect might be related to the expected noncompetition with S phase-specific, pocket protein-E2Fcomplexesfor binding to chromosomal E2F sites by free E2F-l-DP heterodimers, rendered unable to bind DNA by cyclin A-kinase phosphorylation.
Indeed, both, RB-and pl07-containing E2Fcomplexes exist through much of S phase (Shirodkar et al., 1992; Cao et al., 1992; Devoto et al., 1992) , when cyclin A-kinase-E2F-1 complexes are maximally apparent (Krek et al., 1994) .
Whatever the details of the mechanism, assuming that free E2F-DP complexes promote cell growth and pocket protein-E2F complexes contribute to growth control, it seems reasonable to link cyclin A-kinase-E2F-1 binding to the suppression of E2F-1 transforming action. This conclusion notwithstanding, direct analysis of how cyclin A-kinase binding to E2F-1 suppresses its transforming potential is needed.
Although knowledge of the biochemical events connecting cyclin A-kinase-E2F-1 binding and proper S phase control is incomplete, the data presented here suggest that cyclin A-kinase-E2F complex formation represents a possible target for the development of antitumor therapeutic strategies that depend upon the specific action of certain small-molecule compounds.
In principle, compounds that interfere selectively with the cyclin A-kinase-E2F-1 interaction may well lead to death of certain replicating cell types.
Experimental Procedures
Construction of Plasmids The construction of a retroviral expression plasmid encoding HAtagged wild-type E2F-1, pBabe(puro)HA-E2F-l(wt), has been described previously (Xu et al., 1995) . cDNAs encoding HA-tagged versions of E2F-l(A24) and E2F-l(A7) (Krek et al., 1994) were cloned into the retroviral expression plasmid pBabe(puro) (Morgenstern and Land, 1990 ). The plasmids pCMV-E2F-l(E177) (Cress et al., 1993) y;$n A-Kinase-E2F-1 Interaction and Cell Cycle Control and GAL4-RBAP-l(l-368) (Flemington et al., 1993) were converted to pBabe(puro)HA-E2F-I (-DB) and pBabe(puro)HA-E2F-1(-TA). The corresponding double mutant derivates pBabe(puro)HA-E2F-l(A24/ -DB) and pBabe(puro)HA-E2F-l(A24/-TA)
were created from the resulting plasmids.
cDNAs encoding T7-tagged versions of wild-type DP-1 and a mutant derivative of it, DP-l(AP), lacking all potential N-terminal cyclin-cdk phosphoacceptor sites (generated by polymerase chain reaction [PCR] mutagenesis using appropriate mutant oligonucleotides as primers) were also cloned into pBabe(puro). Details of plasmid construction are available upon request.
Cell Culture, DNA Transfection, and Retroviral Infection U2-OS and NIH 3T3 cells were cultivated as described previously (Krek et al., 1994) . The retroviral packaging cell line BOSC23 (Pear et al., 1993) was maintained in DMEM containing 10% fetal calf serum at 37°C in a 10% CO? atmosphere.
Transfection of U2-OS cells was performed as described (Krek et al., 1993) . BOSC23 cells were transfected with a total of 30 Kg Of pBabe(puro) plasmid DNA or its derivatives (containing the indicated HA-tagged E2F-1 alleles) by calcium phosphate coprecipitation, as described (Pear et al., 1993) . Medium containing the retrovirus was harvested 24-30 hr following removal of the precipitate and used to infect NIH 3T3 cells at 30% confluency (see Xu et al., 1995) . Uncloned pools of puromycin-resistant NIH 3T3 were generated as described (Xu et al., 1995 For immunoblotting experiments, whole-cell extracts were prepared (Krek et al., 1993) , and cellular proteins were resolved by SDS-PAGE.
Antibody detection was achieved by ECL-enhanced chemiluminescence (Amersham), according to the protocol of the manufacturer.
Cell Cycle Analysis
and Apoptosis Assays For cell cycle analysis, NIH 3T3 cells were harvested by trypsinization at the indicated times postinfection and processed for FACS analysis, as described (Krek and Nigg, 1991) . Flow cytometric quantitation Of apoptotic cells within the propidium iodide-stained population was also performed as described (Nicoletti et al., 1991) . Chromatin morphology was visualized by staining paraformaldehyde-fixed cells of virus-infected cultures with DAPI at48 hpi. Fragmentation of cellular DNA was measured 48 hr after infection of NIH 3T3 cells with various retroviruses, as described (Lowe et al., 1993) .
Soft Agar Assays and Tumor Formation in Nude Mice Soft agar assays were performed as described (Xu et al., 1995) . TO assay tumor formation in nude mice, uncloned pools of puromycinresistant NIH 3T3 cells producing the various E2F-1 alleles were trypsinized, counted, and resuspended in PBS. Cells in a total volume of 100 ~1 were then injected into 2-to 3-week-old nude mice. Mice were scored for the presence of tumors at the injection sites at weekly intervals. The length (I) and width (w) of tumors was measured with a micrometer, and the approximate ellipsoid tumor volume (tv) was calculated using the equation (I) x (w) x 0.562 = (tv).
